Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Cash from Financing Activities (2021 - 2025)

Rxo (RXO) has disclosed Cash from Financing Activities for 5 consecutive years, with -$3.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities fell 100.28% year-over-year to -$3.0 million, compared with a TTM value of $1.0 million through Dec 2025, down 99.91%, and an annual FY2025 reading of $1.0 million, down 99.91% over the prior year.
  • Cash from Financing Activities was -$3.0 million for Q3 2025 at Rxo, roughly flat from -$3.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.1 billion in Q3 2024 and bottomed at -$145.0 million in Q4 2022.
  • Average Cash from Financing Activities over 5 years is $48.8 million, with a median of -$3.5 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities crashed 417.86% in 2022, then soared 27225.0% in 2024.
  • Year by year, Cash from Financing Activities stood at -$28.0 million in 2021, then plummeted by 417.86% to -$145.0 million in 2022, then soared by 31.03% to -$100.0 million in 2023, then soared by 101.0% to $1.0 million in 2024, then plummeted by 400.0% to -$3.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for RXO at -$3.0 million in Q3 2025, -$3.0 million in Q2 2025, and $7.0 million in Q1 2025.